Hosp. Univ. 12 de Octubre — Madrid

Public research footprint of Hosp. Univ. 12 de Octubre, compiled from the ClinicalTrials.gov public registry.

115

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Carcinoma, Non-Small-Cell Lung · Non-Muscle Invasive Bladder Neoplasms · Squamous Cell Carcinoma of Head and Neck

Recently updated registry entries

NCT05049798 — A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With… (Active Not Recruiting)
NCT05438043 — A Study of Daratumumab (Active Not Recruiting)
NCT07196722 — A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hosp. Univ. 12 de Octubre?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.